These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9383271)

  • 21. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.
    Schmitt CP; Hessing S; Oh J; Weber L; Ochlich P; Mehls O
    Kidney Int; 2000 Apr; 57(4):1484-92. PubMed ID: 10760084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intact parathyroid hormone assay and total calcium concentration in the diagnosis of disorders of calcium metabolism in dogs.
    Torrance AG; Nachreiner R
    J Vet Intern Med; 1989; 3(2):86-9. PubMed ID: 2715961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin.
    DeLuca PP; Dani BA
    AAPS PharmSci; 2001; 3(4):E27. PubMed ID: 12049490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.
    Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; D'Amour P
    Endocrinology; 2001 Apr; 142(4):1386-92. PubMed ID: 11250917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo.
    Weir EC; Terwilliger G; Sartori L; Insogna KL
    Calcif Tissue Int; 1992 Jul; 51(1):30-4. PubMed ID: 1393774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients.
    Lips P; Netelenbos JC; van Doorn L; Hackeng WH; Lips CJ
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):35-40. PubMed ID: 1909609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation by plasma may be responsible for lack of efficacy of parathyroid hormone antagonists in hypercalcemia of malignancy.
    Kukreja SC; D'Anza JJ; Wimbiscus SA; Fisher JE; McKee RL; Caulfield MP; Rosenblatt M
    Endocrinology; 1994 May; 134(5):2184-8. PubMed ID: 8156920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
    Ma YL; Cain RL; Halladay DL; Yang X; Zeng Q; Miles RR; Chandrasekhar S; Martin TJ; Onyia JE
    Endocrinology; 2001 Sep; 142(9):4047-54. PubMed ID: 11517184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist.
    Doppelt SH; Neer RM; Nussbaum SR; Federico P; Potts JT; Rosenblatt M
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7557-60. PubMed ID: 3463984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.
    Yates AJ; Gutierrez GE; Smolens P; Travis PS; Katz MS; Aufdemorte TB; Boyce BF; Hymer TK; Poser JW; Mundy GR
    J Clin Invest; 1988 Mar; 81(3):932-8. PubMed ID: 3343349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathyroid hormone sensitivity in primary hyperparathyroidism and idiopathic hypercalciuria: effects on postadenylate cyclase parameters.
    McElduff A; Lissner D; Wilkinson M; Posen S
    J Clin Endocrinol Metab; 1990 May; 70(5):1457-61. PubMed ID: 2159486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism.
    Ljunghall S; Larsson K; Lindh E; Lindqvist U; Rastad J; Akerström G; Wide L
    Surgery; 1991 Jul; 110(1):47-53. PubMed ID: 1907770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
    Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT
    Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioassay of parathyrin: analytical characteristics and clinical performance in patients with hypercalcemia.
    Klee GG; Preissner CM; Schloegel IW; Kao PC
    Clin Chem; 1988 Mar; 34(3):482-8. PubMed ID: 2832099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium clamp technique: suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism.
    Sørensen HA; Schwarz P; McNair P; Hyldstrup L; Transbøl I
    Scand J Clin Lab Invest; 1992 Oct; 52(6):457-65. PubMed ID: 1411258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of parathyroid hormone on renal calbindin-D28k.
    Hemmingsen C; Staun M; Lewin E; Nielsen PK; Olgaard K
    J Bone Miner Res; 1996 Aug; 11(8):1086-93. PubMed ID: 8854244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
    Nussbaum SR; Potts JT
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal calcaemic response to PTH in the uraemic rat without secondary hyperparathyroidism.
    Berdud I; Martin-Malo A; Almaden Y; Tallon S; Concepcion MT; Torres A; Felsenfeld A; Aljama P; Rodriguez M
    Nephrol Dial Transplant; 1996 Jul; 11(7):1292-8. PubMed ID: 8672025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcitonin, an important factor in the calcemic response to parathyroid hormone in the rat.
    Rodriguez M; Felsenfeld AJ; Torres A; Pederson L; Llach F
    Kidney Int; 1991 Aug; 40(2):219-25. PubMed ID: 1942770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-site assay of intact parathyroid hormone in primary hyperparathyroidism: studies in basal conditions, following adenoma removal and during calcium and EDTA infusion.
    Mazzuoli G; Minisola S; Scarnecchia L; Pacitti MT; Carnevale V; Romagnoli E; Bigi F; Bianchi G
    Clin Chim Acta; 1990 Oct; 190(3):239-48. PubMed ID: 2123754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.